 |
 |
Date Announced: 31 Aug 2011
Clear + Brilliant creates new category of laser aesthetic treatments.
HAYWARD, Calif., Aug. 31, 2011 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq:SLTM - News), the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic skin treatments, today, announced Health Canada approval of its new Clear + Brilliant laser aesthetic treatment.
This technology is now available to physicians in Canada. In May of 2011, the company received FDA 510(K) clearance and CE Mark to market and sell Clear + Brilliant. This revolutionary treatment is an effective treatment based on fractional laser technology that is performed in a professional setting.
The launch of Clear + Brilliant creates and defines an entirely new category of laser aesthetic treatments designed to attract younger patients looking to take control of their aging process. Clear + Brilliant provides a new offering for physicians and skin care providers to address evolving consumer needs and expand their patient base.
In-depth research with patients and their skin care providers revealed an unmet need in the skin care continuum that lies between over the counter or spa treatments and more aggressive laser offerings such as Fraxel. These consumers would like a more efficacious treatment than their current regimens, but as of yet they do not need the full transformative benefits of a more aggressive laser skin resurfacing procedure. They are looking for a treatment solution that refreshes their skin, providing a more youthful appearance.
Unlike other conventional lasers that utilize the stamping delivery method, Clear + Brilliant features a patented Intelligent Optical Tracking System that provides consistent coverage and ensures a uniformly toned treatment area. Each treatment rejuvenates the skin from the inside out by allowing healthy, younger-looking skin to surface and only takes about 20 minutes per treatment session.
"Solta Medical is committed to strengthening our product portfolio and meeting the needs of skin care professionals and their patients," said Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical, Inc. "With the Health Canada approval of our Clear + Brilliant system and worldwide distribution of this product, we are able to reach a whole new professional and consumer base. We are excited to see this product expand our patient base and generate incremental revenue for clinicians and for the Company."
Source: Solta Medical
E-mail: via web site
Web Site: www.solta.com
| © 2024 SPIE Europe |
|
